ClearPoint Neuro (CLPT) Cash & Equivalents (2011 - 2026)
ClearPoint Neuro (CLPT) posted Cash & Equivalents of $35.6 million for Q1 2026, down 22.49% sequentially from $45.9 million in Q4 2025, and up 187.34% YoY from $12.4 million in Q1 2025.
ClearPoint Neuro (CLPT) Cash & Equivalents (2011 - 2026) Analysis & Trends
ClearPoint Neuro has reported Cash & Equivalents for 16 years, with the latest figure at $35.6 million in Q1 2026.
- Quarterly Cash & Equivalents rose 187.34% year-over-year to $35.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.6 million (up 187.34% YoY) and the FY2025 annual result came in at $45.9 million, up 128.47% from the prior year.
- Cash & Equivalents retreated to $35.6 million in Q1 2026 per CLPT's latest filing, from $45.9 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $49.7 million in Q1 2022 and troughed at $12.4 million in Q1 2025.
- A 5-year average of $29.3 million and a median of $26.5 million in 2023 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2022 and 2026: Cash & Equivalents slumped 67.54% in 2022, then jumped 187.34% in 2026.
- Over 5 years, Cash & Equivalents stood at $27.6 million in 2022, then retreated by 16.35% to $23.1 million in 2023, then slipped by 12.99% to $20.1 million in 2024, then soared by 128.47% to $45.9 million in 2025, then retreated by 22.49% to $35.6 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $35.6 million, $45.9 million, and $38.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 482.30 Mn |
| 10 | ClearPoint Neuro | 467.73 Mn | 438.33 Mn | 6.71 Mn | 29.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.40 Mn |
| Mar 31, 2026 | 35.59 Mn |
| Dec 31, 2025 | 45.92 Mn |
| Sep 30, 2025 | 38.20 Mn |
| Jun 30, 2025 | 41.50 Mn |
| Mar 31, 2025 | 12.39 Mn |
| Dec 31, 2024 | 20.10 Mn |
| Sep 30, 2024 | 21.57 Mn |
| Jun 30, 2024 | 32.85 Mn |
| Mar 31, 2024 | 35.35 Mn |
| Dec 31, 2023 | 23.10 Mn |
| Sep 30, 2023 | 24.34 Mn |
| Jun 30, 2023 | 26.50 Mn |
| Mar 31, 2023 | 21.79 Mn |
| Dec 31, 2022 | 27.62 Mn |
| Sep 30, 2022 | 18.71 Mn |
| Jun 30, 2022 | 23.50 Mn |
| Mar 31, 2022 | 49.66 Mn |
| Dec 31, 2021 | 54.10 Mn |
| Sep 30, 2021 | 57.65 Mn |